Bone health and chronic kidney disease: Another reason for partial nephrectomy?

Current Opinion in Urology

Volumn 24, Issue 6, 2014, Pages 629-632

  Derweesh, Ithaar H ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO HEALTH SYSTEM   (United States)

Author keywords

Carcinoma; Chronic renal insufficiency; Nephron sparing surgery; Osteoporosis; Partial nephrectomy; Renal cell

Indexed keywords

CALCIUM;

ARTICLE; BONE; BONE DENSITY; BONE DISEASE; CALCIUM METABOLISM; CANCER SURGERY; CHRONIC KIDNEY DISEASE; DISEASE ASSOCIATION; EVIDENCE BASED PRACTICE; HUMAN; KIDNEY FUNCTION; KIDNEY TUMOR; MEDICAL LITERATURE; NEPHRON; NEPHROSIS; NONHUMAN; ORTHOPEDIC SURGERY; OSTEOLYSIS; OSTEOPOROSIS; PARTIAL NEPHRECTOMY; PRIORITY JOURNAL; SURGICAL INJURY; CARCINOMA, RENAL CELL; CHRONIC KIDNEY FAILURE; COMPLICATION; CONSERVATIVE TREATMENT; KIDNEY NEOPLASMS; METABOLISM; NEPHRECTOMY; PROCEDURES;

BONE AND BONES; CALCIUM; CARCINOMA, RENAL CELL; HUMANS; KIDNEY NEOPLASMS; NEPHRECTOMY; NEPHRONS; ORGAN SPARING TREATMENTS; OSTEOPOROSIS; RENAL INSUFFICIENCY, CHRONIC;

EID: 84927950374     PISSN: 09630643     EISSN: 14736586     Source Type: Journal    
DOI: 10.1097/MOU.0000000000000103     Document Type: Article

References (23)

1. Ljungberg B, Cowan NC, Hanbury DC, et al. EAU guidelines on renal cell carcinoma: the 2010 update. Eur Urol 2010; 58:398-406.
2. Campbell SC, Novick AC, Belldegrun A, et al. Guideline for management of the clinical T1 renal mass. J Urol 2009; 182:1271-1279.
3. Van Poppel H, Da Pozzo L, Albrecht W, et al. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol 2011; 59:543-552.
4. Scosyrev E, Messing EM, Sylvester R, et al. Renal function after nephron-sparing surgery versus radical nephrectomy: results from EORTC randomized trial 30904. Eur Urol 2014; 65:372-377.
5. Russo P. End stage and chronic kidney disease: associations with renal cancer. Front Oncol 2012; 2:28.
6. Malcolm JB, Bagrodia A, Derweesh IH, et al. Comparison of rates and risk factors for developing chronic renal insufficiency, proteinuria and metabolic acidosis after radical or partial nephrectomy. BJU Int 2009; 104:476-481.
7. Bagrodia A, Kopp RP, Mehrazin R, et al. Impact of renal surgery for cortical neoplasms on lipid metabolism. BJU Int 2014. [Epub ahead of Print]
8. Kane CJ, Mallin K, Ritchey J, et al. Renal cell cancer stage migration: analysis of the National Cancer Data Base. Cancer 2008; 113:78-83.
9. Miller DC, Hollingsworth JM, Hafez KS, et al. Partial nephrectomy for small renal masses: an emerging quality of care concern? J Urol 2006; 175:853-857.
10. Weight CJ, Miller DC, Campbell SC, et al. The management of a clinical t1b renal tumor in the presence of a normal contralateral kidney. J Urol 2013; 189:1198-1202.
11. Tan HJ, Norton EC, Ye Z, et al. Long-term survival following partial vs radical nephrectomy among older patients with early-stage kidney cancer. JAMA 2012; 307:1629-1635.
12. Kim SP, Thompson RH, Boorjian SA, et al. Comparative effectiveness for survival and renal function of partial and radical nephrectomy for localized renal tumors: a systematic review and meta-analysis. J Urol 2012; 188:51-57.
13. Carter JL, O'Riordan SE, Eaglestone GL, et al. Bone mineral metabolism and its relationship to kidney disease in a residential care home population: a cross-sectional study. Nephrol Dial Transplant 2008; 23:3554-3565.
14. Jamal SA, Swan VJ, Brown JP, et al. Kidney function and rate of bone loss at the hip and spine: the Canadian Multicentre Osteoporosis Study. Am JKidney Dis 2010; 55:291-299.
15. Mak RH. Early history of renal rickets. Am J Nephrol 1993; 13:293-297.
16. Yenchek RH, Ix JH, Shlipak MG, et al. Bone mineral density and fracture risk in older individuals with CKD. Clin J Am Soc Nephrol 2012; 7:1130-1136.
17. Fried LF, Shlipak MG, Stehman-Breen C, et al. Kidney function predicts the rate of bone loss in older individuals: the Cardiovascular Health Study. J Gerontol A Biol Sci Med Sci 2006; 61:743-748.
18. Jassal SK, von Muhlen D, Barrett-Connor E. Measures of renal function, BMD, bone loss, and osteoporotic fracture in older adults: the Rancho Bernardo study. J Bone Miner Res 2007; 22:203-210.
19. Nazarian A, Cory E, Müller R, Snyder BD. Shortcomings of DXA to assess changes in bone tissue density and microstructure induced by metabolic bone diseases in rat models. Osteoporos Int 2009; 20:123-132.
20. Berger I, Piecha G, Rabkin R, et al. Growth hormone treatment prevents osteoporosis in uremic rats. Histol Histopathol 2007; 22:1231-1239.
21. Shimizu H, Nakagami H, Osako MK, et al. Angiotensin II accelerates osteoporosis by activating osteoclasts. FASEB J 2008; 22:2465-2475.
22. Bagrodia A, Mehrazin R, Bazzi WM, et al. Comparison of rates and risk factors for development of osteoporosis and fractures after radical or partial ne-phrectomy. Urology 2011; 78:614-619.
23. Young A, Hodsman AB, Boudville N, et al. Bone and mineral metabolism and fibroblast growth factor 23 levels after kidney donation. Am J Kidney Dis 2012; 59:761-769.